🫁 Using the IASLC 9th Edition Staging Database, Dr. @Lawson_Eng and colleagues made the case for non-anatomical factors to refine lung cancer staging.
More in ILCN: https://t.co/FY3lBmLgmc
Thank you @myESMO for the incredible opportunity to join global emerging oncology leaders at the F2F #ESMOLDP workshop pre #ESMO25.
Filled with gratitude, inspiration and looking forward to ongoing collaborations 🌏🔬🥼
#myesmostory
Sharing #myESMOStory after our @myESMO Leadership Program meeting🚀
ESMO gave me the opportunity to join this incredible program together with oncologists from different countries in the 🌎, all sharing the same goal of improving cancer care at all levels!
#gratitude@OncoAlert
New @IASLC data show smoking affects #lungcancer survival even within each stage.
People who currently or formerly smoked often had outcomes similar to never-smokers in the next higher stage.
Smoking may now be considered in the 10th TNM staging system.
https://t.co/LdrjBsBWF0
#LCSM
#Smoking isn’t just cause of #LungCancer, it is a #prognostic factor.
Our analysis of @IASLC staging data, @JTOonline led by @Lawson_Eng:
👉#Survival of smokers = survival of never-smokers with one stage higher disease
👉Smoking outweighs some TNM factors
https://t.co/ZYdXyTzrzy
Honored to have been accepted into the @myESMO Leadership Programme 2025–2026
Grateful for the opportunity to learn and grow alongside colleagues from around the world
https://t.co/vZvhKMr4IE
@DFCI_BreastOnc
☑️#WCLC25#LCSM Oral🆙
🔥IASLC 9th Ed TNM
🔥Impact of Smoking on Lung Cancer Prognosis
🎯Those who currently (aHR 1.39, 95%CI 1.34-1.46) and formerly smoked (aHR 1.32, 95%CI 1.27-1.36) had worse OS
🎙️ @Lawson_Eng@OncoAlert@Larvol@IASLC
https://t.co/lbXab16uX1…
Now at #WCLC25 - Smoking is an important prognostic factor that adds to information provided by anatomical staging.
Further exploration of combining smoking status with TNM is planned in the 10th edition IASLC staging. @IASLC@Lawson_Eng
https://t.co/t0D3H1ZwD7
Smoking may weigh more heavily than certain anatomical descriptors in #lungcancer staging. At #WCLC25, researchers explored the impact of #smoking status using the 9th edition TNM. Read more: https://t.co/WgjFnrejMt #LungCancer#Oncology
Our study found that, in early-stage lung cancer, smoking status can have a greater impact on survival outcomes than some traditional staging factors, led by our Clinician Investigator Dr. Lawson Eng and an international team of researchers.
@JTOonline: https://t.co/fKsAoCsAWH
Big congratulations to the 2025 @IASLC Lectureship Award Winners at #WCLC25 including Drs. @HendriksLizza, Mary Beth Beasley, Suresh Senan, @JinMoGoo1, @Lawson_Eng, Kazuhiro Yasufuku, and Andrea Wolf, and a special honor to remember Prof. Ying Cheng.
🏆 Happening now at #WCLC25: @Lawson_Eng of @pmcancercentre, @UHN, @UofT, @UofT_DoM, recipient of the @IASLC Lectureship Award for Tobacco Control & Smoking Cessation, is delivering his award lecture, titled "Why addressing tobacco matters in 2025."
👏 Congratulations, Dr. Eng!
☑️#WCLC25#LCSM Oral🆙
🔥TNM 9th
🔥Impact of Smoking Status on the Prognosis of Lung Cancer in the IASLC Ninth Edition TNM Classification Database
🎙️ Dr. Lawson Eng
@OncoAlert@Larvol@IASLC
https://t.co/anfUDVIYCI
Watch the recording from our recent webinar:
Global Disparities in Supportive Care in Cancer: One Size Does Not Fit All
Speakers: Dr. @EnriqueSoto8, Dr. @Lawson_Eng, Dr. @crisbergerot, and Prof. @alexchan928
https://t.co/sWCwynx2qY
#SuppOnc